(firstQuint)Study to Evaluate the Overall Performance of the Zalviso System (Sufentanil Sublingual Tablet System) 15 mcg.

 Approximately 315 adult postoperative in-patients who are expected to require opioid analgesia for at least 24 hours, and up to 72 hours, after surgery will be enrolled.

 Patients will use the Zalviso cent (sufentanil sublingual tablet system) 15 mcg in order to self-administer a tablet of study drug as needed for pain.

 The System will be evaluated for usability and functionality.

.

 Study to Evaluate the Overall Performance of the Zalviso System (Sufentanil Sublingual Tablet System) 15 mcg@highlight

Patients who meet all inclusion and exclusion criteria at screening and following surgery will receive the Zalviso System cent and evaluate its usability and functionality for up to 72 hours.

